Cold & Cough Remedies (Pharmacies) - Benelux

Revenue in the Cold & Cough Remedies market is projected to reach US$330.90m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.33%, resulting in a market volume of US$389.70m by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$11.01 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in Benelux has been experiencing steady growth in recent years, driven by several factors such as customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Benelux region have been shifting towards self-medication and over-the-counter remedies for common cold and cough symptoms. This can be attributed to the convenience and accessibility of these products in pharmacies. Customers prefer to visit their local pharmacy to purchase remedies for cold and cough symptoms, as they trust the expertise of pharmacists and value their advice on suitable products. Additionally, the increasing awareness about the effectiveness of over-the-counter remedies has led to a rise in their popularity among customers. Trends in the market indicate a growing demand for natural and herbal remedies for cold and cough symptoms. Customers in Benelux are becoming more conscious about the ingredients and potential side effects of pharmaceutical products. As a result, they are seeking natural alternatives that are perceived to be safer and gentler on the body. This trend is reflected in the increasing availability and variety of natural and herbal cold and cough remedies in pharmacies across the region. Local special circumstances in Benelux, such as the high population density and urbanization, contribute to the growth of the Cold & Cough Remedies market. The close proximity of pharmacies to residential areas makes it convenient for customers to access these products. Furthermore, the region's healthcare system, which emphasizes self-care and encourages individuals to manage minor health issues on their own, has created a favorable environment for the growth of the market. Underlying macroeconomic factors also play a role in the development of the Cold & Cough Remedies market in Benelux. The region's stable economy and high disposable income levels enable customers to afford and purchase over-the-counter remedies. Additionally, the aging population in Benelux is driving the demand for cold and cough remedies, as older individuals are more susceptible to respiratory illnesses and seek relief from their symptoms. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Benelux is experiencing growth due to customer preferences for self-medication and over-the-counter remedies, the trend towards natural and herbal products, local special circumstances such as high population density and urbanization, and underlying macroeconomic factors such as a stable economy and an aging population.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.